Celgene Exec Director, Business Development in Summit, New Jersey
Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.
CVP or SVP, Business Development
BS in biology, chemistry, or related science or BA in economics. MBA or PhD/MD preferred. 6- 8 years of experience with above skills in pharmaceutical / biotech industry. Requires expertise in either drug development, sales & marketing or finance.
Responsibilities will include, but are not limited to, the following:
Business Development includes mergers and acquisitions, divestitures, licensing, joint ventures, distribution agreements, and alliances
Lead / Drive evaluation of new business opportunities and lead diligence visits
Lead negotiation teams and formulate proposed offers for business transactions
Leads the operational activities of the department including triage review, semi-annual oncology boards, etc
Ensures the department goals developed by the CVP or SVP BD are tracked and performance maintained at high level
Lead multifunctional diligence and transaction teams to meet near-term goals (e.g. term sheet, definitive language agreements and alliances). Requires leveraging relationships and motivational skills to influence other line functions and Celgene as a Corporation
Interacts on a daily basis with Celgene executive level management. Update management committees on ongoing business discussions as well as leading relationships with investment bankers and industry executives
Concurrently manages 6-8 projects (domestic and international) highly complex business opportunities. Requires prioritization of projects in-line with group and corporate goals
Capable of preparation of all appropriate proposal documents, including market and financial analyses, and leads the project through the approval process
In conjunction with Business Development, acts as a liaison to external advisors such as investment bankers, attorneys and due diligence consultants. Can serve as lead Celgene representative in such matters.
Represents Celgene at external meetings, conferences, seminars to access new opportunities and to develop external network. Can serve as lead Celgene representative in such matters.
Solid leadership potential / skill. Must lead cross-functional deal teams to responsible decision via open communication, dialogue and a “getting to the truth” mentality. Ability to lead via influence vs line authority.
Very strong oral & written communication skills
Strong scientific and industry knowledge.
Ability to work multitask in a small, entrepreneurial environment
Capable of carrying out assigned functions independently in an expeditions and thoughtful manner
Excellent critical thinking skills: An ability to make quantitative and qualitative assessments.
Requires a strategic outlook and ability drive what is best for Celgene, rather than what is best for a part of Celgene.
Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.